Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease

Eastern Mediterranean Health Journal

Volumn 14, Issue 4, 2008, Pages 804-809

  El Karaksy, Hanaa ^a   El Sayed, R ^a   El Raziky, M ^a   El Koofy, N ^a   Mansour, S ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CALCULATION; CHILD; CHRONIC LIVER DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EGYPT; FEMALE; HEPATITIS A; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SCREENING; SEROPREVALENCE; VACCINATION;

AGE DISTRIBUTION; AGE FACTORS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; EGYPT; HEALTH PLANNING GUIDELINES; HEPATITIS A; HEPATITIS A ANTIBODIES; HUMANS; IMMUNIZATION PROGRAMS; LIVER DISEASES; MASS SCREENING; POPULATION SURVEILLANCE; PROGRAM EVALUATION; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 53649111924     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? American journal of gastroenterology, 1995, 90:201-5.
2. Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Canadian journal of public health, 2000, 91:168-70.
3. O'Grady JG. Fulminant hepatitis in patients with chronic liver disease. Journal of viral hepatitis, 2000, 7(Suppl. 1):9-10.
4. Pramoolsinsap C. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand. Journal of viral hepatitis, 2000, 7:11-2.
5. Conteas C et al. Acute type A hepatitis in 3 patients with chronic HBV infection. Digestive diseases and sciences, 1983, 28:648-6.
6. Zachoval R, Roggendorf M, Deinhardt F. Hepatitis A infection in chronic carriers of hepatitis B virus. Hepatology, 1983, 3:528-31.
7. Tassopoulos N et al. Double infection with hepatitis A and B viruses. Liver, 1985, 5:348-53.
8. Vento S et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New England journal of medicine, 1998, 338:286-90.
9. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. Journal of clinical gastroenterology, 2001, 33:20-6.
10. Craig AS, Schaffner W. Prevention of hepatitis A with hepatitis A vaccine. New England journal of medicine, 2004, 350:476-81.
11. Clemens R et al. Clinical experience with an inactivated hepatitis A vaccine. Journal of infectious diseases, 1995, 171(Suppl. 1):S44-9.
12. McMahon BJ et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. Journal of infectious diseases, 1995, 171:676-9.
13. Ashur Y et al. Comparison of immunogenicity of two hepatitis A vaccines - VAQTA and HAVRIX - in young adults. Vaccine, 1999, 17:2290-6.
14. Arankalle VA, Chahda MS. Who should receive hepatitis A vaccine? Journal of viral hepatitis, 2003, 10:157-8.
15. Almasio PL, Amoroso P. HAV infection in chronic liver disease: rationale for vaccination. Vaccine, 2003, 21:2238-41.
16. Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Alimentary pharmacology & therapeutics, 2004, 19:715-27.
17. Battegay M, Naef B, Bucher HC. Hepatitis associated with hepatitis A super infection in patients with chronic hepatitis C. New England journal of medicine, 1998, 338: 1771-2.
18. Jacobs RJ, Koff RS, Meyerhoff AS. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. American journal of gastroenterology, 2002, 97:427-34.
19. Arguedas MR et al. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. American journal of gastroenterology, 2002, 97:721-8.
20. Ferreira CT et al. Prevalência do anticorpo da hepatite A em crianças e adolescentes com hepatopatia crônica [Prevalence of hepatitis A antibody in children and adolescents with chronic liver disease]. Jornal de pediatria, 2002, 78:503-8.
21. Amin J et al. Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Medical journal of Australia, 2001, 174:338-41.
22. Kamal MA et al. Seroepidemiology of hepatitis E virus in the Egyptian Nile Delta. Journal of medical virology, 1995, 47:399-403.
23. Acharya SK et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. Journal of gastroenterology and hepatology, 2003, 18:822-7.
24. Koçak N et al. Prevalence of hepatitis A antibodies in children with chronic liver disease and other gastrointestinal diseases. European journal of pediatrics, 1999, 158:869-70.